$23.10 $0.77 per serving
Product analysis
CoQ10 400 mg may offer limited support for blood-vessel function and blood-fat measures in selected adults.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality26
The CoQ-10 preparation is unspecified, limiting comparison of absorption. Vitamin E has a named form, but its quality cannot be compared confidently here.
Ingredient Transparency70
The ingredient amounts are clearly stated. Most forms remain unspecified, including CoQ-10, which limits preparation comparisons.
Value For Money40
The CoQ-10 contribution is less competitively priced per serving. The vitamin E and lecithin contributions cannot be judged confidently for value.
Customer Satisfaction74
Customer ratings are very positive. The smaller review count gives a narrower picture of satisfaction.
Product Focus71
The clearest intended use concerns CoQ-10 and cardiovascular measures, where results are limited and mixed. The larger serving does not establish proportionately better cardiovascular, energy or metabolism benefits.
- Format
Softgel - Container
- 30 Softgel(s)
- Per serving
- $0.77
- Customer rating
- 4.7 · 231 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 400 mgVitamin E · 20 mg
CoQ10 has limited support for blood-pressure, lipid and vessel-function markers in adults with abnormal blood lipids. The findings concern measured markers and do not establish cardiovascular-event prevention. Higher amounts do not establish proportionately larger benefits. Optional repeat servings are not assumed.
How this product is rated for Cardiovascular Support
Ingredient fit79
Skin-related ingredients appear within a broader formula with other intended uses. The counted amounts meet the comparison range, without establishing that larger intakes improve cardiovascular further.
Goal fit
Skin-related ingredients appear within a broader formula with other intended uses.
Dose adequacy
The counted amounts meet the comparison range, without establishing that larger intakes improve cardiovascular further.
Pathways60
Endothelial nitric-oxide function is the strongest assigned cardiovascular role; the result does not establish the complete product's clinical effect. The recorded reach is concentrated in one cardiovascular role.
Depth
Endothelial nitric-oxide function is the strongest assigned cardiovascular role; the result does not establish the complete product's clinical effect.
Breadth
The recorded reach is concentrated in one cardiovascular role.
Evidence88
Coenzyme Q-10 leads the evidence finding, subject to its specific clinical and population limitations. The counted ingredients match the saved preparation requirements, without confirming a trial of this complete formula.
Evidence strength
Coenzyme Q-10 leads the evidence finding, subject to its specific clinical and population limitations.
Studied preparation
The counted ingredients match the saved preparation requirements, without confirming a trial of this complete formula.
Formulation logic100
The evaluated ingredients have no missing required partner or configured conflict. All counted amounts pass the minimum comparison.
Partner coverage
No required partner is missing from the counted ingredients; this does not establish an additional combination benefit.
Conflicts
No configured conflict was identified among the evaluated ingredients.
Effective doses
All counted ingredients pass the minimum amount comparison; passing it does not prove a clinical cardiovascular benefit.
Impact
High effect
Coenzyme Q-10 · 400 mg
Coenzyme Q10 may support blood-pressure, lipid and blood-vessel measures in selected adults, with mixed results across studies. This product provides 400 mg per serving, above the conventional amounts underlying the comparison, without evidence that the larger serving works better. Findings concern these intermediate measures and do not establish prevention of heart attacks or other cardiovascular events.
How this product is rated for Heart Health
Ingredient fit59
Heart-related ingredients sit within a broader formula with other active ingredients. The relevant declared amounts provide partial coverage of the saved exposure comparison.
Goal fit
Heart-related ingredients sit within a broader formula with other active ingredients.
Dose adequacy
The relevant declared amounts provide partial coverage of the saved exposure comparison.
Pathways47
The strongest saved connection is to blood-vessel function. Coverage across other heart-related roles is limited.
Depth
The strongest saved connection is to blood-vessel function.
Breadth
The broader saved findings cover blood-vessel function. .
Evidence98
Coenzyme Q-10 leads the saved evidence finding. Accepted preparation matches do not remove the ingredient-specific limitations described above.
Evidence strength
Coenzyme Q-10 provides the leading evidence contribution in the saved comparison; its clinical limitations still apply.
Studied preparation
The saved finding accepts the preparations used for its included ingredients; it does not establish that every labelled preparation matches a clinical trial.
Formulation logic100
The saved checks find no missing required partner or configured conflict. The included amounts pass the minimum comparison screen.
Partner coverage
The included ingredients do not lack a required partner under the saved finding; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients included in this amount screen meet its minimum comparison level; that level is not a proven effective dose.
Impact
High effect
Coenzyme Q-10 · 400 mg
Vitamin E functions as a fat-soluble antioxidant, and CoQ10 participates in cellular energy processes. Those normal roles do not establish an anti-aging benefit. The CoQ10 preparation is unidentified and cannot inherit the selected wrinkle and smoothness findings reported for Q10Vital; its larger serving amount does not resolve that preparation difference.
How this product is rated for Longevity
Ingredient fit75
Most of the saved amount comparison is met, with some ingredients contributing less at the declared serving.
Goal fit
Relevant ingredients sit within a broader formula with ingredients serving other purposes, reducing its focus on this goal.
Dose adequacy
Most of the saved amount comparison is met, with some ingredients contributing less at the declared serving.
Pathways65
The strongest identified connection is antioxidant processes. This describes ingredient roles rather than demonstrated slowing of aging.
Depth
The strongest identified connection is antioxidant processes. This describes ingredient roles rather than demonstrated slowing of aging.
Breadth
The supplied findings identify cellular energy production, antioxidant processes.
Evidence60
Vitamin E provides the strongest evidence contribution in the saved findings, with benefits limited to the conditions and outcomes described above.
Evidence strength
Vitamin E provides the strongest evidence contribution in the saved findings, with benefits limited to the conditions and outcomes described above.
Studied preparation
Preparation matching is incomplete for Coenzyme Q-10, limiting transfer of findings from specific studied products.
Formulation logic100
The evaluated ingredients have no unmet partner requirement or configured conflict.
Partner coverage
The evaluated ingredients have no unmet partner requirement in the supplied findings; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The evaluated ingredients meet the saved minimum amount threshold; this is not proof of an effective anti-aging dose.
Impact
High effect
Coenzyme Q-10 · 400 mgVitamin E · 20 mg
CoQ10 is relevant to oxidative and mitochondrial stress, with limited evidence for changes in inflammatory markers. The studied ubiquinone regimen used 300 mg daily for 12 weeks in people with coronary artery disease taking statins; some markers changed while others did not. This serving supplies 400 mg, so its amount does not establish the same regimen or routine clinical benefit.
How this product is rated for Inflammation
Ingredient fit72
CoQ10 is the main relevant ingredient. Other actives reduce the formula’s focus on this goal.
Goal fit
CoQ10 provides the main relevant ingredient focus; other actives make the formula less focused on this goal.
Dose adequacy
The 400 mg serving differs from the reviewed 300 mg daily regimen; the amount alone does not establish equivalent benefit.
Pathways52
The contribution is concentrated in oxidative and mitochondrial stress, rather than broad coverage of the assessed inflammatory routes.
Depth
CoQ10 supplies the main contribution in oxidative and mitochondrial stress.
Breadth
Only oxidative and mitochondrial stress reaches the coverage threshold; the other assessed routes add no coverage.
Evidence93
CoQ10 supplies the main evidence connection, with a reviewed ubiquinone preparation and context-limited biomarker findings.
Evidence strength
CoQ10 leads the evidence finding, based on limited biomarker results in statin-treated coronary artery disease.
Studied preparation
The supplied policy treats unspecified CoQ10 as ordinary ubiquinone, the reviewed preparation.
Formulation logic100
CoQ10 can contribute independently, with no configured ingredient conflict identified.
Partner coverage
CoQ10 can contribute without a required companion ingredient.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
CoQ10 meets the amount threshold used for inclusion; this is not a proven effective clinical dose.
Impact
High effect
Coenzyme Q-10 · 400 mg
Coenzyme Q-10 helps the cellular machinery that transfers energy, but this normal role does not establish that supplementation increases whole-body calorie expenditure. The supplied studies concern metabolic markers rather than a general increase in metabolic rate. Its known amount receives a saved contribution, without demonstrating thermogenesis or sustained weight loss.
How this product is rated for Metabolism Support
Ingredient fit72
Coenzyme Q-10 supplies the saved ingredient contribution, but its normal cellular role does not establish increased whole-body energy expenditure.
Goal fit
Other actives broaden the formula beyond this goal, reducing its focus.
Dose adequacy
The counted amounts reach the saved comparison range; that range is not a proven dose for increasing calorie expenditure.
Pathways54
The strongest saved functional coverage concerns mitochondrial energy and fat oxidation. That mechanism does not by itself establish greater whole-body energy expenditure.
Depth
The strongest saved contribution concerns mitochondrial energy and fat oxidation, with partial functional coverage.
Breadth
The saved findings cover mitochondrial energy and fat oxidation; other functions remain less supported.
Evidence75
Coenzyme Q-10 is the strongest saved evidence contributor. The supplied scientific context does not establish a routine increase in calorie expenditure.
Evidence strength
Coenzyme Q-10 supplies the strongest saved evidence contribution; this does not override limitations in the direct energy-expenditure findings.
Studied preparation
The counted amounts match preparations accepted in the saved comparison.
Formulation logic100
The counted ingredients can contribute independently and no configured conflict is found. Their known amounts pass the saved minimum.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The counted amounts pass the saved minimum, which does not establish a proven increase in energy expenditure.
Impact
Moderate effect
Coenzyme Q-10 · 400 mg
CoQ10 at 400 mg has a role in cellular energy production and limited evidence for fatigue support. The unidentified redox form makes preparation-specific findings less directly applicable, and the larger amount does not establish a larger energy benefit.
How this product is rated for Energy
Ingredient fit72
Energy-relevant ingredients sit alongside ingredients directed at other uses, giving the formula a broader focus. The credited ingredient reaches the full amount used in the saved assessment.
Goal fit
Energy-relevant ingredients sit alongside ingredients directed at other uses, giving the formula a broader focus.
Dose adequacy
The credited ingredient reaches the full amount used in the saved assessment.
Pathways17
The strongest saved contribution concerns mitochondrial energy production, with partial coverage. No selected energy pathway reaches the saved threshold for substantial coverage.
Depth
The strongest saved contribution concerns mitochondrial energy production, with partial coverage.
Breadth
No selected energy pathway reaches the saved threshold for substantial coverage.
Evidence27
Coenzyme Q-10 provides the strongest saved evidence among ingredients at an assessed effective amount; the practical benefit remains dependent on context. The CoQ10 redox form is unidentified, so it is not matched to a studied preparation.
Evidence strength
Coenzyme Q-10 provides the strongest saved evidence among ingredients at an assessed effective amount; the practical benefit remains dependent on context.
Studied preparation
The CoQ10 redox form is unidentified, so it is not matched to a studied preparation.
Formulation logic100
The credited ingredients can contribute independently or have their required partners. No configured ingredient conflicts were recorded in the saved findings. All credited ingredients meet the saved minimum amount.
Partner coverage
The credited ingredients can contribute independently or have their required partners.
Conflicts
No configured ingredient conflicts were recorded in the saved findings.
Effective doses
All credited ingredients meet the saved minimum amount.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 5 Calorie(s) | |
Total Fat | 0.5 Gram(s) | |
Vitamin E (D-Alpha-Tocopherol) | 20 mg | |
Coenzyme Q10 | 400 mg | |
Sunflower Lecithin | 35 mg |
Coenzyme Q-10 · 400 mg OverallScore42
Each serving provides 400 mg of CoQ10, but the saved facts do not identify its form. The missing form makes a form-specific comparison of absorption and amount uncertain.
How this ingredient is rated
Active Ingredient Quality & Bioavailability12
The CoQ10 form is not identified in the saved facts, limiting a form-specific absorption comparison.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify the CoQ10 form, so a form-specific absorption comparison is not possible.
Formulation & Absorption Enhancers
The saved facts do not establish a specified absorption-enhancing technology or black pepper extract.
Dose, Safety & Label Transparency72
The stated CoQ10 amount is 400 mg per serving, although the form remains unknown.
Clinical Dosage Alignment
The serving contains 400 mg of CoQ10, but the unknown form prevents a form-specific assessment.
Label Transparency & Fillers
The CoQ10 amount is clear, and the evaluation flags no standard fillers or specified problematic additives.
Value40
A whole-product serving costs about $0.77, toward the higher end of the comparison. The price covers the entire product.
Price Per Effective Serving
A whole-product serving costs about $0.77, toward the higher end of the comparison.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
- Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
- Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
- Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
- Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.